CirCode

About:

CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.

Website: https://www.circodebio.com/

Top Investors: Johnson & Johnson Innovation – JJDC, K2VC, Kaitai Capital, EFung Capital, Kunlun Capital

Description:

CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.

Total Funding Amount:

$20M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2021-01-01

Contact Email:

info(AT)circodebio.com

Founders:

Zefeng Wang

Number of Employees:

Last Funding Date:

2023-08-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai